source
- FDA forms new board to guide drug exclusivity decisions as Roche reexamines German investmentsThe U.S. Food and Drug Administration's Center for Drug Evaluation and Research has created a board to oversee and advise on drug exclusivity decisions. Reuters reports the board is intended to imp…
- Nonprofit arbitrators under No Surprises Act earning large profits, investigation findsA recent STAT investigation examined the role of nonprofit organizations that serve as arbitrators under the No Surprises Act. The report found that these entities are generating substantial revenu…